One of the world's leading global French nuclear medicine, Curium Pharma has acquired the "Eczacıbaşı-Monrol Nükleer Ürünler" operating company in Istanbul. It should be noted that the company specializes in the production of radioactive materials used in diagnosis and treatment of cancer.
"Eczacıbaşı Monrol" is one of several producers of "Lutetium-177" (LU177) in the world and the company's "GA-68 generator" is used in the early diagnosis of some types of cancer.
It is noted that as a result of the deal with the French company, Turkey will become not only a country that meets its own needs, but also a research base.
